AwnyFarajallahMD

PubMed

• 8 citations
  Changes in bone mineral density after 96 weeks of treatment with atazanavir/ritonavir or lopinavir/ritonavir plus tenofovir DF/emtricitabine in treatment-naive patient...
  Graeme J. Moyle, Helene Hardy, Awny Farajallah, St John McGrath, Stephen Kaplita, Douglas J. Ward> ;Journal of Acquired Immune Deficiency Syndromes. 2015 Jan 1
• 18 citations
  Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study
  Li Zhu, Shanmei Liao, Michael Child, Jenny Zhang, Anna Persson, Heather Sevinsky, Timothy Eley, Xiaohui Xu, Mark Krystal, Awny Farajallah, Donnie McGrath, Jean-Michel ...> ;The Journal of Antimicrobial Chemotherapy. 2012 Feb 1
• 146 citations
  Abacavir/Lamivudine Versus Tenofovir DF/Emtricitabine as Part of Combination Regimens for Initial Treatment of HIV: Final Results
  Paul E. Sax, Camlin Tierney, Ann C. Collier, Eric S. Daar, Katie R. Mollan, Chakra Budhathoki, Catherine Godfrey, Nasreen C. Jahed, Laurie Myers, David Katzenstein, Aw...> ;The Journal of Infectious Diseases. 2011 Oct 15
• 19 citations
  Determination of rifabutin dosing regimen when administered in combination with ritonavir-boosted atazanavir
  Jenny Zhang, Li Zhu, Michele Stonier, John Coumbis, Xiaohui Xu, Yaoshi Wu, Dilek Arikan, Awny Farajallah, Richard Bertz> ;The Journal of Antimicrobial Chemotherapy. 2011 Sep 1
• 3 citations
  Treatment of advanced HIV disease in antiretroviral-naïve HIV-1-infected patients receiving once-daily atazanavir/ritonavir or twice-daily lopinavir/ritonavir, each in...
  Jonathan Uy, Rong Yang, Victoria Wirtz, Louise Sheppard, Awny Farajallah, Donnie McGrath> ;AIDS Care. 2011 Jun 16
• 69 citations
  Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and ...
  Sally Hodder, Karam Mounzer, Edwin DeJesus, Ramin Ebrahimi, Kristy Grimm, Stephen Esker, Janet Ecker, Awny Farajallah, John F. Flaherty> ;AIDS Patient Care and Stds. 2010 Feb 15
• 239 citations
  Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.
  Paul E. Sax, Camlin Tierney, Ann C. Collier, Margaret A. Fischl, Katie R. Mollan, Lynne Peeples, Catherine Godfrey, Nasreen C. Jahed, Laurie Myers, David Katzenstein, ...> ;The New England Journal of Medicine. 2009 Dec 16
• 103 citations
  Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiret...
  Edwin DeJesus, Benjamin Young, Javier O Morales-Ramirez, Louis Sloan, Douglas J. Ward, John F. Flaherty, Ramin Ebrahimi, Jen-Fue Maa, Karen Reilly, Janet Ecker, Damian...> ;Journal of Acquired Immune Deficiency Syndromes. 2009 Jun 1
• 50 citations
  Escherichia coli: Development of Carbapenem Resistance During Therapy
  Tao Hong, Ellen Smith Moland, Baha Abdalhamid, Nancy D. Hanson, Jie Wang, Cindy Sloan, Diane Fabian, Awny Farajallah, Jerome Levine, Kenneth S. Thomson> ;Clinical Infectious Diseases. 2005 May 15
• Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.
  Daar, E. S., Tierney, C., Fischl, M. A., Sax, P. E., Mollan, K., Budhathoki, C., Godfrey, C., Jahed, N. C., Myers, L., Katzenstein, D., Farajallah, A., Rooney, J. F., ...> ;Ann Intern Med. 2011 Apr 5
• Join now to see all